... pharmacological management. With 2/3 of epilepsy able to be properly managed with treatment, 1/3 is considered ...
... , and it is estimated 1 in 26 people in the U.S. will develop the disease at some point in their ...
... negative impact on a patients quality of life. The 3 major neurostimulatory devices on the market today ...
... ) focal and refractory seizures Deep Brain Stimulator (DBS) focal and refractory seizures The 3 main ...
... presentation without evidence of focal or generalized onset. 1. Understanding the onset of seizures for ...